Synthesis, characterization of isoxazole derivatives and evaluation of their antibacterial, antioxidant and anticancer activity

dc.contributor.authorVashisht, Ketan
dc.contributor.authorSethi, Pooja
dc.contributor.authorBansal, Anshul
dc.contributor.authorSingh, Tejveer
dc.contributor.authorKumar, Raman
dc.contributor.authorTuli, Hardeep Singh
dc.contributor.authorSaini, Shallu
dc.date.accessioned2024-06-19T18:34:35Z
dc.date.available2024-06-19T18:34:35Z
dc.date.issued2024-06
dc.description.abstractIntroduction and aim. The synthesis of heterocyclic compounds containing oxygen and nitrogen is profoundly intriguing due to their mechanistic implications in both research and development within organic chemistry and drug discovery. The primary aim of this study is to fabricate a range of pharmacologically active drugs containing the isoxazole moiety. Material and methods. The synthesis of new derivatives of isoxazole was achieved through a one-pot condensation reaction of 2-[(Substituted phenyl)hydrazono]malononitrile (1) and 3-[(Substituted phenyl)azo]-2,4-Pentanedione (2) with sodium acetate and hydroxylamine hydrochloride (1:1) in ethanol. All the compounds were screened for their in vitro antibacterial activity, in vitro antioxidant and anticancer activity. The synthesized compounds underwent characterization through FTIR, 1 H NMR, and 13C NMR analyses, supported by mass spectral data and elemental analysis. Results. A set of novel isoxazole derivatives was synthesized with a favorable yield. Among compounds 1d, 1e, 2c, 2d, and 2e exhibited notable antioxidant activities. Compounds 1a, 1b, and 1c demonstrated significant anticancer potential against prostate cancer [PC3] cell lines compared to normal HEK cell lines, while 2a displayed the highest inhibitory zone against Escherichia coli. Conclusion. Novel compounds with multifaceted biological activities have been successfully designed, and a synthetic route to create isoxazole derivatives has been devised and verified.eng
dc.description.sponsorshipFinancial support from the MM (DU) Education Trust management is available to facilitate the execution of this research.
dc.identifier.citationEuropean Journal of Clinical and Experimental Medicine T. 22, z. 2 (2024), s. 376-387
dc.identifier.doi10.15584/ejcem.2024.2.25
dc.identifier.eissn2544-1361
dc.identifier.urihttps://repozytorium.ur.edu.pl/handle/item/10611
dc.language.isoeng
dc.publisherPublishing Office of the University of Rzeszow
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Poland*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/pl/*
dc.subjectantibacterial
dc.subjectantioxidant activity and anticancer potential
dc.subjectisoxazole
dc.subjectpathogenic bacterial
dc.titleSynthesis, characterization of isoxazole derivatives and evaluation of their antibacterial, antioxidant and anticancer activity
dc.typearticle

Pliki

Oryginalny pakiet

Aktualnie wyświetlane 1 - 1 z 1
Ładowanie...
Obrazek miniatury
Nazwa:
18.synthesis_characterization_of_isoxazole_derivatives_and_evaluation_of_their_antibacterial_antioxidant_and_anticancer_activity_0.pdf
Rozmiar:
641.43 KB
Format:
Adobe Portable Document Format

Pakiet licencji

Aktualnie wyświetlane 1 - 1 z 1
Nazwa:
license.txt
Rozmiar:
1.28 KB
Format:
Item-specific license agreed upon to submission
Opis: